期刊文献+

人恶性胶质瘤细胞裸鼠脑原位移植瘤FPR表达与VEGF关系 被引量:1

Relationship between expression of formylpeptide receptor in the orthotopic transplantation tumors of malignant human glioblastoma cell line U87
下载PDF
导出
摘要 目的观测甲酰肽受体(formylpeptide receptor,FPR)在人恶性胶质瘤细胞系U87细胞裸鼠脑原位移植瘤组织中的表达,以及与血管内皮生长因子(VEGF)的关系,探讨FPR在恶性胶质瘤血管生成过程中的作用。方法培养U87细胞,以立体定向注射技术制作U87裸鼠脑原位移植瘤模型;采用间接免疫荧光染色在激光共聚焦显微镜下分别观测FPR在U87细胞和移植瘤组织的表达;免疫组化方法检测VEGF在U87细胞裸鼠脑移植瘤上的表达。结果培养的U87细胞及其原位移植瘤组织均可见FPR表达,定位于瘤细胞胞膜,VEGF阳性着色主要位于胞质,两者阳性表达程度呈正相关性。结论人恶性胶质瘤细胞系U87细胞裸鼠脑原位移植瘤组织存在FPR表达,与VEGF的产生密切相关,在胶质瘤血管生成过程中可能起重要作用。 Purpose To observe the relationship between the expression of formylpeptide receptor (FPR) and production of vascular endothelial growth factor (VEGF) in human glioma ceil line U87 orthotopic transplantation tumors in the brains of nude mice, and to explore the potential roles of FPR during the angiogenesis of malignant glioma. Methods An orthotopic implantation of U87 cells with stereotactic technique in nude mouse brain was used. By indirect immunofluorescence staining combined with confocal laser scanning microscopy, the expression and localization of FPR in U87 cells and its orthotopic transplantation tumor tissues were detected. Results FPR was expressed in U87 cells and its orthotopic transplantation tumor tissues. FPR was n,ainly located at plasma membranes whereas VEGF was mainly found in the cytoplasm of neoplastic cells. In addition, the expression levels of FPR and VEGF were positively correlated in the tumor cells. Conclusions The human glioblastoma cell line, U87 and its orthotopic transplantation tumor have the formylpeptide receptor (FPR) , whose expression and activation are closely correlated with production of VEGF. Thus it might be of much importance in progression and neoangiogenesis of malignant gliomas.
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2006年第5期600-603,共4页 Chinese Journal of Clinical and Experimental Pathology
基金 国家自然科学基金资助(No30370552u)
关键词 脑肿瘤 胶质瘤 甲酰化肽受体 血管内皮生长因子 血管生成 brain neoplasms glioma formylpeptide receptor vascular endothelial growth factor angiogenesis
  • 相关文献

参考文献14

  • 1Le Y,Sun R, Ying G, et al. The role of peptide receptors in microbial infection and inflammation [ J ]. Curr Med Chem Anti-Infect Agents,2003, ( 2 ) : 83 - 93.
  • 2Le Y , Hu J Y, Gong W H, et al. Expression of functional formyl peptide receptors by human astrocytoma cell lines[ J]. J Neuroimmunol, 2000,111 : 102 - 108.
  • 3Beeker E L, Forouhar F A, Grunnet M L, et al. Broad immunocytochemical localization of the formylpeptide receptor in human organs, tissues and cells[ J]. Cell Tissue Res, 1998, 292:129 -135.
  • 4Zhou Y, Bian X W, Le Y Y, et al. Formyl peptide receptor FPR and the rapid growth of malignant human gliomas[ J]. J Nat Cancer Inst,2005,97 ( 11 ) :823 - 835.
  • 5徐承平,卞修武.人CHG-5胶质瘤细胞裸鼠原位移植模型的建立及其生物学特性分析[J].第三军医大学学报,2003,25(4):287-290. 被引量:6
  • 6Mokry J,Nemeeek S, Adler J,et al. Inoculation of C6 cell suspension into the brain of aduh rats immunohistochemical study [ J ].Funct Dev Morph ,1993 ,(3):175-180.
  • 7Le Y, Murphy P M, Wang J M. Formyl-peptide receptors revisited[ J]. Trends hnmuno1,2002, (23) :541 - 548.
  • 8Chen J H, Bian X W, Yao X H, et al. Nordy, a synthetic lipoxygenase inhibitor ,inhibits the expression of formylpeptide receptor and induces differentiation of malignant glioma cells[ J]. Biochem Biophy Res Comm, 2006, 342:1368- 1374.
  • 9Bian X W, Chen J H, Jiang X F, et al. Angiogenesis as an immunopharmacologic target in inflammation and cancer[ J ]. Inter Immunopharmacologic, 2004, (4) : 1537 - 1547.
  • 10Senger D R, Galli S J, Dyorak A M, et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid[J]. Science, 1983,219(4587) :983 -985.

二级参考文献2

共引文献5

同被引文献15

  • 1刘宏,卞修武,陈代伦,赵雯,陈剑鸿,冯玉慧,徐承平.诺帝对人恶性胶质瘤裸鼠原位移植瘤FPR、VEGF表达的影响及意义[J].中国微侵袭神经外科杂志,2007,12(2):72-75. 被引量:4
  • 2姚小红,卞修武,平轶芳,陈剑鸿,王清良,蒋雪峰.恶性胶质瘤细胞甲酰化肽受体表达及其活化后促瘤细胞增殖和血管生成因子产生的作用[J].癌症,2007,26(3):241-246. 被引量:1
  • 3李晓明.血管内皮细胞生长因子及其受体与肿瘤血管形成[J].国外医学(肿瘤学分册),1997,24(1):11-13. 被引量:54
  • 4Folkerth RD. Descriptive analysis and quantification of angiogenesis in human tumors. J Neurooncol, 2000, 50 (1-2): 165-172.
  • 5Puduvalli UK, Sawaga R. Antiangiogenesis therapeutic strategies and clinical implications for brain tumors. J Neurooncol, 2000, 50(1-2):189-200.
  • 6Lund EL, Bastholm L, Kristjansen PE. Therapeutic synergy of TNP-470 and ionizing radiation: effects on tumor growth, vessel morphology, and angiogenesis in human glioblastoma multiforme xenografts. Clin Cancer Res, 2000, 6:971-978.
  • 7Weidner N. Current pathologic methods for measuring intratumoral microvessel density with breast carcinoma and other solid tumors. Breast Cancer Res Treat, 1995, 36: 169-175.
  • 8Sin N, Meng L, Wang M, et al. The antiangiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase. Proc Natl Acad Sci USA, 1997, 94:6099-6103.
  • 9Herbst RS, Madden TL, Tran HT, et al. Safety and pharmacokinetic effects of TNP-470, an angiogenesis inhibitor, combined with paclitaxel in patients with solid tumors: evidence for activity in non-small-cell lung cancer. J Clin Oncol, 2002, 20: 4440-4447.
  • 10Kudelka AP, Levy T, Versehraegen CF, et al. A phase Ⅰ study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix. Clin Cancer Res, 1997,3 : 1501-1505.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部